EpiWatch Announces FDA-Cleared Seizure Detection and Alerting App Now Available for Direct Download
Digital care to enhance safety for people living with epilepsy
BALTIMORE, MD, UNITED STATES, September 30, 2025 /EINPresswire.com/ — EpiWatch, Inc. today announced that its app-based product, EpiWatch, an FDA-cleared and clinically validated mobile application for seizure detection, alerting and monitoring, is now available for direct download on the Apple App Store.
EpiWatch is indicated for use in individuals with epilepsy ages 5 and older experiencing tonic-clonic seizures. The app provides seizure detection and alerting via text, phone or email to caregivers, family members and other care contacts, empowering patients and reducing anxiety for caregivers.
